US Patent 7402730 Knockout animals manifesting hyperlipidemia
Patent 7402730 was granted and assigned to Lexicon Pharmaceuticals, Inc. on July, 2008 by the United States Patent and Trademark Office.
All edits
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Mary Jean Sparks0
Wenhu Huang0
Edits on 14 Sep, 2023
Golden AI
Edits made to:
Article (+234 characters)
Article
Patent abstract
Genetically engineered cells and animals are described that incorporate a mutated GHP1 allele. Animals that are homozygous for the mutated GHP1 allele are useful for the production of monoclonal antibodies against GHP1.
Edits on 15 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07402730 Knockout animals manifesting hyperlipidemia US Patent 7402730 Knockout animals manifesting hyperlipidemia
Infobox
Patent Number
074027300
Patent Number
74027300
Edits on 26 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
074027300
Date of Patent
July 22, 2008
0Patent Application Number
113478380
Date Filed
February 3, 2006
0Official Website
Patent Primary Examiner
Edits on 9 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 30 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07402730 Knockout animals manifesting hyperlipidemia
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07402730
Date of patent
July 22, 2008
Patent application number
11347838
Date Filed
February 3, 2006
Patent primary examiner
Find more entities like US Patent 7402730 Knockout animals manifesting hyperlipidemia
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
